Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.
Stanfield, R.L., Gorny, M.K., Zolla-Pazner, S., Wilson, I.A.(2006) J Virol 80: 6093-6105
- PubMed: 16731948 
- DOI: 10.1128/JVI.00205-06
- Primary Citation of Related Structures:  
2B1H, 2B1A, 2B0S - PubMed Abstract: 
Human monoclonal antibody 2219 is a neutralizing antibody isolated from a human immunodeficiency virus type 1-infected individual. 2219 was originally selected for binding to a V3 fusion protein and can neutralize primary isolates from subtypes B, A, ...